Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

NQ-304, a novel platelet antiaggregatory and antithrombotic agent in early development

Aug. 12, 1998

Menarini's NK1 antagonist MEN-11467 shows promising antiasthmatic activity

Aug. 12, 1998

Dual ETA/ETB antagonist provides effective blood pressure control in rats

Aug. 11, 1998

OPC-51803, a vasopressin V2 agonist with potent antidiuretic activity in rats and dogs

Aug. 11, 1998

RS-601, a dual-action TxA2/LTD4 antagonist with potent antiasthmatic effects

Aug. 11, 1998

New antiplatelet agent, PDE III inhibitor, reported by Taiwanese scientists

Aug. 11, 1998

New agents for treating constipation presented at IUPHAR meeting

Aug. 11, 1998

COX-2 inhibitors selective for the human enzyme discovered at Nycomed Innovations

Aug. 11, 1998

Israeli investigators describe studies with novel vitamin D analogue

Aug. 11, 1998

Japanese investigators study antinociceptive dynorphin analogue

Aug. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...